[Biochemical and clinical aspects of pyrophosphate metabolism. V. The activity of inorganic pyrophosphatase (E. C. 3.6.1.1) in human and rat kidney during varying orthophosphate uptake].
D000469:Alkaline Phosphatase / Q000037:antagonists & inhibitors; D000818:Animals; D001706:Biopsy; D003609:Dactinomycin / Q000494:pharmacology; D011756:Diphosphates / Q000378:metabolism*; D004347:Drug Interactions; D004789:Enzyme Activation; D004794:Enzyme Repression; D005504:Food Analysis; D006207:Half-Life; D006801:Humans; D007668:Kidney / Q000201:enzymology / Q000378:metabolism*; D010710:Phosphates / Q000032:analysis / Q000378:metabolism* / Q000494:pharmacology; D011755:Pyrophosphatases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D051381:Rats; D013997:Time Factors
D011756:Diphosphates; D010710:Phosphates; D003609:Dactinomycin; D000469:Alkaline Phosphatase; D011755:Pyrophosphatases
Biochemische und klinische Aspekte des Pyrophosphatstoffwechsels. V. Die Aktivität der anorganischen Pyrophosphatase (E. C. 3.6.1.1) in der Niere von Mensch und Ratte bei unterschiedlicher Orthophosphataufnahme.